Evaluation of patients' experiences with antidepressants reported by means of a medicine reporting system

European Journal of Clinical Pharmacology

Volumn 63, Issue 12, 2007, Pages 1193-1199

  Van Geffen, E C G ^a   Van Der Wal, S W ^a   Van Hulten, R ^b   De Groot, M C H ^c   Egberts, A C G ^b   Heerdink, E R ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c NETHERLANDS PHARMACOVIGILANCE CENTRE LAREB   (Netherlands)

Author keywords

Adverse events; Antidepressants; Discontinuation; Patient reporting

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CITALOPRAM; MIRTAZAPINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ABDOMINAL PAIN; ADULT; ANXIETY; APATHY; ARTHROPATHY; ARTICLE; CONGENITAL DISORDER; CONVULSION; DEPRESSION; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG USE; DRUG WITHDRAWAL; EPILEPSY; EVALUATION; EXPERIENCE; EXTRAPYRAMIDAL SYNDROME; EYE DISEASE; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEALTH CARE PERSONNEL; HEART ARRHYTHMIA; HUMAN; INSOMNIA; INTERNET; MAJOR CLINICAL STUDY; MALE; MENSTRUATION DISORDER; MUSCLE DISEASE; NAUSEA; PARESTHESIA; PARKINSONISM; PRIORITY JOURNAL; PRURITUS; REIMBURSEMENT; SEROTONIN SYNDROME; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; SUICIDAL IDEATION; SUICIDE ATTEMPT; SWEATING; SYNCOPE; TREATMENT FAILURE; URTICARIA; VAGINA BLEEDING; VISUAL DISORDER; WEIGHT GAIN; XEROSTOMIA;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTIDEPRESSIVE AGENTS; FEMALE; HUMANS; INTERNET; MALE; NETHERLANDS; TREATMENT REFUSAL;

EID: 36148944423     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-007-0375-4     Document Type: Article

References (21)

1. Lin EHB, Von Korff M, Katon W, Bush T, Simon ES, Walker E, Robinson P (1995) The role of the primary care physician in patients' adherence to antidepressant therapy. Med Care 33:67-74
2. Meijer WEE, Bouvy ML, Heerdink ER, Urquhart J, Leufkens HMG (2001) Spontaneous lapses in dosing during chronic treatment with selective serotonin reuptake inhibitors. Br J Psychiatry 179:519-522
3. Bambauer KZ, Adams AS, Zhang F, Minkoff N, Grande A, Weisblatt R, Soumerai SB, Ross-Degnan D (2006) Physicians alerts to increase antidepressant adherence. Arch Intern Med 166:498-504
4. Cohen N, Parikh SV, Kennedy SH (2000) Medication compliance in mood disorders: relevance of the Healt Belief Model and other determinants. Prim Care Psychiatry 6:101-110
5. Lingam R, Scott J (2002) Treatment non-adherence in affective disorders. Acta Psychiatr Scand 105:164-172
6. van Dijk L, Heerdink E, Somai D, van Dulmen S, Sluijs E, de Ridder D, Griens AMGF, Bensing JM (2007) Patient risk profiles and practice variation in non adherence to antidepressants, antihypertensives and oral hypoglycemics. BMC Health Serv Res 7:51-61
7. Bull SA, Hunkeler EM, Lee JY, Rowland CR, Williamson TE, Schwab JR, Hurt SW (2002) Discontinuation or switching selective serotonin-reuptake inhibitors. Ann Pharmacother 36:578-584
8. Demyttenaere K, Enzlin P, Dewé W, Boulanger B, Bie JD, Troyer WD, Mesters P (2001) Compliance with antidepressants in a primary care setting, 1: beyond lack of efficacy and adverse events. J Clin Psychiatry 62[Suppl 22]:30-33
9. Vergouwen ACM, Bakker A, Katon WJ, Verheij TJ, Koerselman F (2003) Improving adherence to antidepressants: a systematic review of interventions. J Clin Psychiatry 64:1415-1420
10. Pampallona S, Bollini B, Tibaldi G, Kupelnick B, Munizza C (2002) Patient adherence in the treatment of depression. Br J Psychiatry 180:104-109
11. Egberts ACG, Smulders M, De Koning FHP, Meyboom RHB, Leufkens HMG (1996) Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals. Br Med J 313:530-531
12. Anonymous (2001) International monitoring of adverse reactions to drugs. Adverse reaction terminology. WHO Collaborating Centre for International Drug Monitoring, Uppsala
13. Van Puijenbroek E, Grootheest VAC, Diemont WL, Leufkens HGM, Egberts ACG (2002) Determinants of signal selection in a spontaneous reporting system for adverse drug reactions. Br J Clin Pharmacol 52:579-586
14. Meyboom RHB, Lindquist M, Flygare A-K, Biriell C, Edwards IR (2000). The value of reporting therapeutic ineffectiveness as an adverse drug reaction. Drug Safety 23:95-99
15. Mitchell AJ (2006) High medication discontinuation rates in psychiatry. How often is it understandable? J Clin Psychopharmacol 26:109-112
16. Hu XH, Bull SA, Hunkeler EM, Ming EE, Lee JY, Fireman B, Markson LE (2004) Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient reports versus physician estimate. J Clin Psychiatry 65:959-965
17. Eland IA, Belton KJ, Grootheest vAC, Meiners AP, Rawlins MD, Stricker BHC (1999) Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol 48:623-627
18. Inman W, Rawson N, Wilton L, Pearce G, Speirs C (1988) Post-marketing surveillance of enalapril I: results of prescription-event monitoring. Br Med J 297:826-829
19. Blenkinsopp A, Wilkie P, Wang M, Routledge P (2006) Patient reporting of suspected adverse drug reactions: a review of published experience. Br J Clin Pharmacol 63:148-156
20. Van Grootheest AC, Passier JL, Van Puijenbroek EP (2005) Direct reporting of side effects by the patient: favourable experience in the first year. Ned Tijdschr Geneeskunde 149:529-533
21. Aikens JE, Nease DE, Nau DP, Klinkman MS, Schwenk TL (2005) Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication. Ann Fam Med 3:23-30